How should investors evaluate Recursion Pharmaceuticals Inc (NASDAQ:RXRX)?
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, down -3.02% to $9.00. RXRX stock price is now 19.12% away from the 50-day moving average and 20.38% away from the 200-day moving average. The market capitalization of the company currently stands at $3.52B. With the price target of $8, Morgan Stanley […]
Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric
In Tuesday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $10.64, up 1.04% from the previous session. RXRX stock price is now 44.46% away from the 50-day moving average and 42.75% away from the 200-day moving average. The market capitalization of the company currently stands at $4.16B. With the price target of $8, […]
Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric
In Tuesday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $10.64, up 1.04% from the previous session. RXRX stock price is now 44.46% away from the 50-day moving average and 42.75% away from the 200-day moving average. The market capitalization of the company currently stands at $4.16B. With the price target of $8, […]
The shares of Recursion Pharmaceuticals Inc (RXRX) have recorded the market capitalization of 2.99B
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $7.65, up 2.14% from the previous session. RXRX stock price is now 7.26% away from the 50-day moving average and 3.04% away from the 200-day moving average. The market capitalization of the company currently stands at $2.99B. With the price target of $8, Morgan Stanley […]
Does Recursion Pharmaceuticals Inc (NASDAQ:RXRX) have deteriorating prospects?
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded 4.97% higher at $7.61 on Wall Street last session. RXRX stock price is now 8.77% away from the 50-day moving average and 2.51% away from the 200-day moving average. The market capitalization of the company currently stands at $2.97B. With the price target of $8, Morgan Stanley recently initiated […]
Why Recursion Pharmaceuticals Inc (RXRX) Should Be On Your Radar Moving Forward
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $7.03, down -4.09% from the previous session. RXRX stock price is now 1.65% away from the 50-day moving average and -5.58% away from the 200-day moving average. The market capitalization of the company currently stands at $2.75B. With the price target of $8, Morgan Stanley […]
The most important numbers to know about Recursion Pharmaceuticals Inc (NASDAQ:RXRX)
The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $6.53, up 2.03% from the previous session. RXRX stock price is now -5.41% away from the 50-day moving average and -12.78% away from the 200-day moving average. The market capitalization of the company currently stands at $2.55B. With the price target of $8, Morgan Stanley […]
How Do Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s Fundamentals Affect Performance
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.76, down -0.15% from the previous session. RXRX stock price is now -0.70% away from the 50-day moving average and -11.86% away from the 200-day moving average. The market capitalization of the company currently stands at $2.64B. With the price target of $8, […]
Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric
In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.03, down -0.99% from the previous session. RXRX stock price is now -10.82% away from the 50-day moving average and -22.50% away from the 200-day moving average. The market capitalization of the company currently stands at $2.33B. With the price target of $8, […]
The most important numbers to know about Recursion Pharmaceuticals Inc (NASDAQ:RXRX)
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded -0.43% lower at $6.95 on Wall Street last session. RXRX stock price is now 3.35% away from the 50-day moving average and -12.18% away from the 200-day moving average. The market capitalization of the company currently stands at $2.69B. With the price target of $8, Morgan Stanley recently initiated […]
